Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?

Heart. 2017 Jun;103(11):807-808. doi: 10.1136/heartjnl-2016-310540. Epub 2017 Jan 9.

Authors

Eric Black-Maier¹, Jonathan P Piccini^{1

2}

Affiliations

¹ Duke Center for Atrial Fibrillation, Duke University Medical Center, Durham, North Carolina, USA.
² Duke Clinical Research Institute, Durham, North Carolina, USA.

PMID: 28069637
DOI: 10.1136/heartjnl-2016-310540

No abstract available

Publication types

Editorial
Comment

MeSH terms

Administration, Oral
Anticoagulants
Atrial Fibrillation*
Blood Coagulation / drug effects
Humans
Kidney Failure, Chronic*
Stroke
Thrombolytic Therapy

Substances

Anticoagulants